Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Pfizer and Moderna raise prices for COVID-19 vaccines in EU- FT

08/01/2021 | 08:14am EDT
busFILE PHOTO: Picture illustration of vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels

Aug 1 (Reuters) - Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported https://on.ft.com/3j8mbTb on Sunday.

The new price for the Pfizer shot was 19.50 euros ($23.15)against 15.50 euros previously, the newspaper said, citing portions of the contracts seen.

The price of a Moderna vaccine was $25.50 a dose, the contracts show, up from about 19 euros in the first procurement deal but lower than the previously agreed $28.50 because the order had grown, the report said, citing one official close to the matter.

Pfizer declined to comment on the contract with the European Commission, citing confidentiality. "Beyond the redacted contract(s) published by the EC, the content remains confidential and so we won't be commenting," the company said.

Moderna was not immediately available for comment to Reuters.

The European Commission said on Tuesday that the EU is on course to hit a target of fully vaccinating at least 70% of the adult population by the end of the summer.

In May, the EU said it expects to have received more than a billion doses of vaccines by the end of September from four drugmakers.

($1 = 0.8425 euros) (Reporting by Sabahatjahan Contractor in Bengaluru, additional reporting by Aakriti Bhalla; Editing by Louise Heavens, Giles Elgood and Diane Craft)


ę Reuters 2021
All news about MODERNA, INC.
09/20MODERNA : U.S. administers 386.2 mln doses of COVID-19 vaccines - CDC
RE
09/20MODERNA : U.S. CDC Says Administered About 386.2 Million Doses Of Covid-19 Vacci..
RE
09/20MODERNA : Regulators could OK Pfizer boosters for older Americans this week
RE
09/20MODERNA : Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in ..
RE
09/20INSIDER SELL : Moderna
MT
09/20MODERNA : Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in ..
RE
09/20MODERNA : Regulators expected to OK Pfizer boosters for older Americans this wee..
RE
09/19MODERNA : U.S. administers about 385.6 mln doses of COVID-19 vaccines -CDC
RE
09/19MODERNA : U.S. CDC Says Administered 385,586,012 Doses Of COVID-19 Vaccine As Of..
RE
09/19MODERNA : Key data on U.S. J&J, Moderna COVID-19 boosters weeks away, Fauci says
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 348 M - -
Net income 2021 12 529 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 14,2x
Yield 2021 -
Capitalization 171 B 171 B -
EV / Sales 2021 7,76x
EV / Sales 2022 7,16x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 423,33 $
Average target price 306,23 $
Spread / Average Target -27,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.305.22%170 876
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.41.30%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-9.18%28 420
ALNYLAM PHARMACEUTICALS, INC.41.16%22 621